Skip to main content

2019 Human Microbiome Market to Contribute $1,197.08 Million by 2025 profiling MicroBiome Therapeutics, Rebiotix, Yakult Honsha, Osel, Vedanta Biosciences, Metabiomics Corporate

Press release   •   Aug 07, 2019 15:44 IST

Human Microbiome Market

The market for human microbiome is expected to grow as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing are expected to fuel the market growth during the forecast period. In addition, the human microbiome – a new frontier in drug discovery is likely to have a positive impact on the growth of the market in the coming years.

According to a new market research study titled ‘Human Microbiome Market to 2025 – Global Analysis and Forecasts by Product, Disease and Application. The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. The report highlights the trends prevalent in the global human microbiome market and the factors driving the market along with those that act as deterrents to its growth.

Get Sample Report at https://www.theinsightpartners.com/sample/TIPBT00002233

Increasing Incidence of Lifestyle Diseases

Over the past few decades, human microbiome is related to lifestyle diseases like cancer, diabetes, obesity, depression and many others. Changes in lifestyles and societal norms influence the microbiome at each stage of life. Altering the human microbiome can help in eliminating such lifestyle diseases. As per World health organization in 2016, 13% of the world population (adults) were obese. According to the “The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation” published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity. Therefore, fecal/gut microbiome transplantation (GMT), which involves the transfer of feces from a healthy donor to the patient, is a potential treatment for obesity

Growing Technological Advancements in Metagenomics and Next-generation Sequencing

Technological advancements in metagenomics and next-generation sequencing have made microbiome-based testing easier and cheaper, and have led to rapid analysis of the genomic content of microorganisms from human sample. This has bolstered the development process for microbiome-based diagnostics. Gastrointestinal and metabolic disorders are likely to capture the leading share of the diagnostics market in 2018 owing to rise in interest of companies toward developing an easy analysis platform for gut health-based disorders, such as irritable bowel syndrome and Crohn’s disease. Although cancer is likely to capture a minor share of the market in 2018, much lower than gut health and metabolic disorders, it is a niche operating area for the company involved in developing a diagnostic test for detecting cancer. For instance, Metabiomics is developing molecular diagnostics for detecting markers of colorectal cancer. Existing tests for colorectal cancer rely on invasive colonoscopies; and thus, the non-invasive test developed by Metabiomics (which uses a stool sample to evaluate patient’s gut microbiome)

Disease Insights

The human microbiome market by disease was segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders and other diseases. The obesity segment held the largest share of the market, by disease. The segment is also likely to dominate in the forecast period, due to increase in the cases of obesity, caused due to various factors such as, lifestyle changes, sedentary lifestyle as well as unhealthy eating habits.

Inquire about Discount at https://www.theinsightpartners.com/discount/TIPBT00002233

TABLE OF CONTENTS

1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. GLOBAL HUMAN MICROBIOME MARKET – KEY TAKEAWAYS

3. GLOBAL HUMAN MICROBIOME MARKET – MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 Global Human Microbiome Market – By Product
3.2.2 Global Human Microbiome Market – By Disease
3.2.3 Global Human Microbiome Market – By Application
3.2.4 Global Human Microbiome Market – By Geography
3.3 PEST ANALYSIS
3.3.1 North America – PEST Analysis
3.3.2 Europe– PEST Analysis
3.3.3 Asia Pacific– PEST Analysis
3.3.4 Middle East And Africa– PEST Analysis
3.3.5 South and Central America – PEST Analysis

4. GLOBAL HUMAN MICROBIOME MARKET – KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Increasing Incidence of Lifestyle Diseases
4.1.2 Increasing Focus On Human Microbiome Therapies
4.1.3 Growing Technological Advancements in Metagenomics and Next-generation Sequencing
4.2 KEY MARKET RESTRAINTS
4.2.1 Stringent Government Regulations
4.2.2 Lack of Knowledge Limiting the Growth of Market
4.3 KEY MARKET OPPORTUNITIES
4.3.1 New Drug Requirements for Faecal Microbiota
4.3.2 Emerging Nations
4.4 FUTURE TRENDS
4.4.1 The Human Microbiome – A New Frontier in Drug Discovery
4.5 IMPACT ANALYSIS

5. HUMAN MICROBIOME MARKET – GLOBAL ANALYSIS
5.1 GLOBAL HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS
5.2 GLOBAL HUMAN MICROBIOME MARKET, BY GEOGRAPHY – FORECASTS AND ANALYSIS
5.3 MARKET POSITIONING
5.4 PERFORMANCE OF KEY PLAYERS
5.4.1 Enterome
5.4.2 Yakult Honsha Co., Ltd.
5.5 EXPERT OPINIONS

Buy This Report now at https://www.theinsightpartners.com/buy/TIPBT00002233

Contact us –

Phone : +1-646-491-9876

Email Id : sales@theinsightpartners.com

Website: https://www.theinsightpartners.com

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.